Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

Patient information sources when facing repair of abdominal aortic aneurysm.

Anderson PB, Wanken ZJ, Perri JL, Columbo JA, Kang R, Spangler EL, Newhall K, Brooke BS, Dosluoglu H, Lee ES, Raffetto JD, Henke PK, Tang GL, Mureebe L, Kougias P, Johanning J, Arya S, Scali ST, Stone DH, Suckow BD, Orion K, Halpern V, O'Connell J, Inhat D, Nelson P, Tzeng E, Zhou W, Barry M, Sirovich B, Goodney PP; PROVE-AAA Study Team.

J Vasc Surg. 2019 Jul 25. pii: S0741-5214(19)31127-9. doi: 10.1016/j.jvs.2019.04.460. [Epub ahead of print]

PMID:
31353272
2.

Population Pharmacokinetics of an Anti-PD-L1 Antibody, Durvalumab in Patients with Hematologic Malignancies.

Ogasawara K, Newhall K, Maxwell SE, Dell'Aringa J, Komashko V, Kilavuz N, Delarue R, Czuczman M, Sternas L, Rose S, Beach CL, Novick S, Zhou S, Palmisano M, Li Y.

Clin Pharmacokinet. 2019 Jul 22. doi: 10.1007/s40262-019-00804-x. [Epub ahead of print]

PMID:
31332669
3.

Design of The PReferences for Open Versus Endovascular Repair of Abdominal Aortic Aneurysm (PROVE-AAA) Trial.

Columbo JA, Kang R, Spangler EL, Newhall K, Brooke BS, Dosluoglu H, Lee ES, Raffetto JD, Henke PK, Tang GS, Mureebe L, Kougias P, Johanning J, Arya S, Scali ST, Stone DH, Suckow BD, Orion K, Halpern V, O'Connell J, Inhat D, Nelson P, Tzeng E, Zhou W, Barry M, Sirovich B, Goodney PP; PROVE-AAA Study Team.

Ann Vasc Surg. 2019 May 7. pii: S0890-5096(19)30289-4. doi: 10.1016/j.avsg.2019.02.034. [Epub ahead of print] Review.

PMID:
31075459
4.

Inferring information flow in spike-train data sets using a trial-shuffle method.

Walker BL, Newhall KA.

PLoS One. 2018 Nov 7;13(11):e0206977. doi: 10.1371/journal.pone.0206977. eCollection 2018.

5.

Parenting stress and DNA methylation among African Americans in the InterGEN Study.

Wright ML, Huang Y, Hui Q, Newhall K, Crusto C, Sun YV, Taylor JY.

J Clin Transl Sci. 2017 Dec;1(6):328-333. doi: 10.1017/cts.2018.3. Epub 2018 Mar 12.

6.

Reply.

Newhall KA, Stone DH, Goodney PP.

J Vasc Surg. 2017 Sep;66(3):968-969. doi: 10.1016/j.jvs.2017.06.066. No abstract available.

PMID:
28842081
7.

Feasibility and pilot efficacy of a brief smoking cessation intervention delivered by vascular surgeons in the Vascular Physician Offer and Report (VAPOR) Trial.

Goodney PP, Spangler EL, Newhall K, Brooke BS, Schanzer A, Tan TW, Beck AW, Hallett JH, MacKenzie TA, Edelen MO, Hoel AW, Rigotti NA, Farber A.

J Vasc Surg. 2017 Apr;65(4):1152-1160.e2. doi: 10.1016/j.jvs.2016.10.121. Epub 2017 Feb 9. Erratum in: J Vasc Surg. 2018 Jun;67(6):1946.

8.

Cost-effectiveness of prophylactic appendectomy: a Markov model.

Newhall K, Albright B, Tosteson A, Ozanne E, Trus T, Goodney PP.

Surg Endosc. 2017 Sep;31(9):3596-3604. doi: 10.1007/s00464-016-5391-y. Epub 2017 Jan 11.

PMID:
28078461
9.

Possible consequences of regionally based bundled payments for diabetic amputations for safety net hospitals in Texas.

Newhall K, Stone D, Svoboda R, Goodney P.

J Vasc Surg. 2016 Dec;64(6):1756-1762. doi: 10.1016/j.jvs.2016.06.098.

10.

Impact and Duration of Brief Surgeon-Delivered Smoking Cessation Advice on Attitudes Regarding Nicotine Dependence and Tobacco Harms for Patients with Peripheral Arterial Disease.

Newhall K, Suckow B, Spangler E, Brooke BS, Schanzer A, Tan TW, Burnette M, Edelen MO, Farber A, Goodney P; VAPOR investigators.

Ann Vasc Surg. 2017 Jan;38:113-121. doi: 10.1016/j.avsg.2016.06.005. Epub 2016 Aug 10.

11.

Consistency of Hemoglobin A1c Testing and Cardiovascular Outcomes in Medicare Patients With Diabetes.

Goodney PP, Newhall KA, Bekelis K, Gottlieb D, Comi R, Chaudrain S, Faerber AE, Mackenzie TA, Skinner JS.

J Am Heart Assoc. 2016 Aug 10;5(8). pii: e003566. doi: 10.1161/JAHA.116.003566.

12.

Hemoglobin A1c Testing and Amputation Rates in Black, Hispanic, and White Medicare Patients.

Suckow BD, Newhall KA, Bekelis K, Faerber AE, Gottlieb DJ, Skinner JS, Stone DH, Goodney PP.

Ann Vasc Surg. 2016 Oct;36:208-217. doi: 10.1016/j.avsg.2016.03.035. Epub 2016 Jul 27.

13.

Trends in the Diagnosis and Outcomes of Traumatic Carotid and Vertebral Artery Dissections among Medicare Beneficiaries.

Newhall K, Gottlieb DJ, Stone DH, Goodney PP.

Ann Vasc Surg. 2016 Oct;36:145-152. doi: 10.1016/j.avsg.2016.06.001. Epub 2016 Jun 29.

14.

Relationships between 2-Year Survival, Costs, and Outcomes following Carotid Endarterectomy in Asymptomatic Patients in the Vascular Quality Initiative.

Wallaert JB, Newhall KA, Suckow BD, Brooke BS, Zhang M, Farber AE, Likosky D, Goodney PP; Vascular Quality Initiative.

Ann Vasc Surg. 2016 Aug;35:174-82. doi: 10.1016/j.avsg.2016.01.024. Epub 2016 May 26.

15.

The relationship of regional hemoglobin A1c testing and amputation rate among patients with diabetes.

Newhall KA, Bekelis K, Suckow BD, Gottlieb DJ, Farber AE, Goodney PP, Skinner JS.

Vascular. 2017 Apr;25(2):142-148. doi: 10.1177/1708538116650099. Epub 2016 Jul 9.

16.

Does Rapid Diffusion of HbA1c Testing Affect Amputation Rates?

Bekelis K, Gottlieb D, Newhall K, Faerber A, Goodney P.

Vasc Endovascular Surg. 2016 Mar 8. pii: 1538574416637436. [Epub ahead of print]

17.

Smoking cessation counseling in vascular surgical practice using the results of interviews and focus groups in the Vascular Surgeon offer and report smoking cessation pilot trial.

Newhall K, Burnette M, Brooke BS, Schanzer A, Tan T, Flocke S, Farber A, Goodney P; VAPOR Investigators.

J Vasc Surg. 2016 Apr;63(4):1011-7.e2. doi: 10.1016/j.jvs.2015.10.086. Epub 2015 Dec 30.

18.

Amputation Rates for Patients with Diabetes and Peripheral Arterial Disease: The Effects of Race and Region.

Newhall K, Spangler E, Dzebisashvili N, Goodman DC, Goodney P.

Ann Vasc Surg. 2016 Jan;30:292-8.e1. doi: 10.1016/j.avsg.2015.07.040. Epub 2015 Nov 5.

19.

Use of Protamine for Anticoagulation During Carotid Endarterectomy: A Meta-analysis.

Newhall KA, Saunders EC, Larson RJ, Stone DH, Goodney PP.

JAMA Surg. 2016 Mar;151(3):247-55. doi: 10.1001/jamasurg.2015.3592. Review.

PMID:
26501944
20.

The Broad Anti-AML Activity of the CD33/CD3 BiTE Antibody Construct, AMG 330, Is Impacted by Disease Stage and Risk.

Harrington KH, Gudgeon CJ, Laszlo GS, Newhall KJ, Sinclair AM, Frankel SR, Kischel R, Chen G, Walter RB.

PLoS One. 2015 Aug 25;10(8):e0135945. doi: 10.1371/journal.pone.0135945. eCollection 2015.

22.

Synchrony in stochastically driven neuronal networks with complex topologies.

Newhall KA, Shkarayev MS, Kramer PR, Kovačič G, Cai D.

Phys Rev E Stat Nonlin Soft Matter Phys. 2015 May;91(5):052806. Epub 2015 May 11.

PMID:
26066211
23.

Development and pilot feasibility study of a health information technology tool to calculate mortality risk for patients with asymptomatic carotid stenosis: the Carotid Risk Assessment Tool (CARAT).

Faerber AE, Horvath R, Stillman C, O'Connell ML, Hamilton AL, Newhall KA, Likosky DS, Goodney PP.

BMC Med Inform Decis Mak. 2015 Mar 24;15:20. doi: 10.1186/s12911-015-0141-y.

24.

AMG 925 is a dual FLT3/CDK4 inhibitor with the potential to overcome FLT3 inhibitor resistance in acute myeloid leukemia.

Li C, Liu L, Liang L, Xia Z, Li Z, Wang X, McGee LR, Newhall K, Sinclair A, Kamb A, Wickramasinghe D, Dai K.

Mol Cancer Ther. 2015 Feb;14(2):375-83. doi: 10.1158/1535-7163.MCT-14-0388. Epub 2014 Dec 8.

25.

Preclinical development of AMG 139, a human antibody specifically targeting IL-23.

Köck K, Pan WJ, Gow JM, Horner MJ, Gibbs JP, Colbert A, Goletz TJ, Newhall KJ, Rees WA, Sun Y, Zhang Y, O'Neill JC, Umble-Romero AN, Prokop SP, Krill CD, Som L, Buntich SA, Trimble MW, Tsuji WH, Towne JE.

Br J Pharmacol. 2015 Jan;172(1):159-72. doi: 10.1111/bph.12904. Epub 2014 Dec 15.

26.

Predicting outcomes of oral food challenges by using the allergen-specific IgE-total IgE ratio.

Gupta RS, Lau CH, Hamilton RG, Donnell A, Newhall KK.

J Allergy Clin Immunol Pract. 2014 May-Jun;2(3):300-5. doi: 10.1016/j.jaip.2013.12.006. Epub 2014 Mar 29.

PMID:
24811021
27.

Mutations affecting the SAND domain of DEAF1 cause intellectual disability with severe speech impairment and behavioral problems.

Vulto-van Silfhout AT, Rajamanickam S, Jensik PJ, Vergult S, de Rocker N, Newhall KJ, Raghavan R, Reardon SN, Jarrett K, McIntyre T, Bulinski J, Ownby SL, Huggenvik JI, McKnight GS, Rose GM, Cai X, Willaert A, Zweier C, Endele S, de Ligt J, van Bon BW, Lugtenberg D, de Vries PF, Veltman JA, van Bokhoven H, Brunner HG, Rauch A, de Brouwer AP, Carvill GL, Hoischen A, Mefford HC, Eichler EE, Vissers LE, Menten B, Collard MW, de Vries BB.

Am J Hum Genet. 2014 May 1;94(5):649-61. doi: 10.1016/j.ajhg.2014.03.013. Epub 2014 Apr 10.

28.

Cellular determinants for preclinical activity of a novel CD33/CD3 bispecific T-cell engager (BiTE) antibody, AMG 330, against human AML.

Laszlo GS, Gudgeon CJ, Harrington KH, Dell'Aringa J, Newhall KJ, Means GD, Sinclair AM, Kischel R, Frankel SR, Walter RB.

Blood. 2014 Jan 23;123(4):554-61. doi: 10.1182/blood-2013-09-527044. Epub 2013 Dec 5.

29.

Distribution of correlated spiking events in a population-based approach for Integrate-and-Fire networks.

Zhang J, Newhall K, Zhou D, Rangan A.

J Comput Neurosci. 2014 Apr;36(2):279-95. doi: 10.1007/s10827-013-0472-6. Epub 2013 Jul 13.

PMID:
23851661
30.

Random polarization dynamics in a resonant optical medium.

Newhall KA, Atkins EP, Kramer PR, Kovačič G, Gabitov IR.

Opt Lett. 2013 Mar 15;38(6):893-5. doi: 10.1364/OL.38.000893.

PMID:
23503251
31.

Size-topology relations in packings of grains, emulsions, foams, and biological cells.

Newhall KA, Pontani LL, Jorjadze I, Hilgenfeldt S, Brujic J.

Phys Rev Lett. 2012 Jun 29;108(26):268001. Epub 2012 Jun 26.

PMID:
23005016
32.

Pharmacokinetics of spinosad and milbemycin oxime administered in combination and separately per os to dogs.

Holmstrom SD, Totten ML, Newhall KB, Qiao M, Riggs KL.

J Vet Pharmacol Ther. 2012 Aug;35(4):351-64. doi: 10.1111/j.1365-2885.2011.01333.x. Epub 2011 Sep 6.

PMID:
21895692
33.

Attractive emulsion droplets probe the phase diagram of jammed granular matter.

Jorjadze I, Pontani LL, Newhall KA, Brujic J.

Proc Natl Acad Sci U S A. 2011 Mar 15;108(11):4286-91. doi: 10.1073/pnas.1017716108. Epub 2011 Feb 28.

34.

Safety evaluation and treatment affect of LY2190416, a CB-1 antagonist/inverse agonist in growing beagle dogs.

Nunamaker E, Newhall K, Thompson C, Lucas A, Owens J, Sherman JG.

J Vet Pharmacol Ther. 2011 Dec;34(6):577-82. doi: 10.1111/j.1365-2885.2011.01280.x. Epub 2011 Feb 17.

PMID:
21323931
35.

Cascade-induced synchrony in stochastically driven neuronal networks.

Newhall KA, Kovačič G, Kramer PR, Cai D.

Phys Rev E Stat Nonlin Soft Matter Phys. 2010 Oct;82(4 Pt 1):041903. Epub 2010 Oct 1.

PMID:
21230309
36.

CB-1 antagonism with LY2190416 results in acute weight loss in obese adult dogs fed a high-fat diet.

Newhall K, Nunamaker E, Gissendanner S, Thompson C, Owens J, Lucas A, Sherman JG.

J Vet Pharmacol Ther. 2010 Dec;33(6):615-8. No abstract available.

PMID:
21108507
37.

Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects.

Huntington Study Group Pre2CARE Investigators, Hyson HC, Kieburtz K, Shoulson I, McDermott M, Ravina B, de Blieck EA, Cudkowicz ME, Ferrante RJ, Como P, Frank S, Zimmerman C, Cudkowicz ME, Ferrante K, Newhall K, Jennings D, Kelsey T, Walker F, Hunt V, Daigneault S, Goldstein M, Weber J, Watts A, Beal MF, Browne SE, Metakis LJ.

Mov Disord. 2010 Sep 15;25(12):1924-8. doi: 10.1002/mds.22408.

PMID:
20669312
38.

Evidence for endotoxin contamination in plastic Na+-heparin blood collection tube lots.

Newhall KJ, Diemer GS, Leshinsky N, Kerkof K, Chute HT, Russell CB, Rees W, Welcher AA, Patterson SD, Means GD.

Clin Chem. 2010 Sep;56(9):1483-91. doi: 10.1373/clinchem.2006.144618. Epub 2010 Jul 27.

39.

Nonlinear mixed effects pharmacokinetic/pharmacodynamic analysis of the anticonvulsant ameltolide (LY201116) in a canine seizure model.

Territo PR, Shannon HE, Newhall K, Barnhart SD, Peters SC, Engleking DR, Bin T, Burnett TJ, Rodewald JM, Abdul-Karim B, Freise KJ.

J Vet Pharmacol Ther. 2008 Dec;31(6):562-70. doi: 10.1111/j.1365-2885.2008.00995.x.

PMID:
19000280
40.

Metabolomic analysis and signatures in motor neuron disease.

Rozen S, Cudkowicz ME, Bogdanov M, Matson WR, Kristal BS, Beecher C, Harrison S, Vouros P, Flarakos J, Vigneau-Callahan K, Matson TD, Newhall KM, Beal MF, Brown RH Jr, Kaddurah-Daouk R.

Metabolomics. 2005;1(2):101-108.

41.

Development and validation of the maximal electro-shock seizure model in dogs.

Territo PR, Freise KJ, Newhall K, Barnhart SD, Peters SC, Engleking DR, Burnett TJ, Abdul-Karim B, Shannon HE.

J Vet Pharmacol Ther. 2007 Dec;30(6):508-15.

PMID:
17991218
42.

Analysis of factors that modify susceptibility and rate of progression in amyotrophic lateral sclerosis (ALS).

Qureshi MM, Hayden D, Urbinelli L, Ferrante K, Newhall K, Myers D, Hilgenberg S, Smart R, Brown RH, Cudkowicz ME.

Amyotroph Lateral Scler. 2006 Sep;7(3):173-82.

PMID:
16963407
43.

Identification of potential CSF biomarkers in ALS.

Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L.

Neurology. 2006 Apr 25;66(8):1218-22. Epub 2006 Feb 15.

PMID:
16481598
44.

Dynamic anchoring of PKA is essential during oocyte maturation.

Newhall KJ, Criniti AR, Cheah CS, Smith KC, Kafer KE, Burkart AD, McKnight GS.

Curr Biol. 2006 Feb 7;16(3):321-7.

45.

Tolerance of high-dose (3,000 mg/day) coenzyme Q10 in ALS.

Ferrante KL, Shefner J, Zhang H, Betensky R, O'Brien M, Yu H, Fantasia M, Taft J, Beal MF, Traynor B, Newhall K, Donofrio P, Caress J, Ashburn C, Freiberg B, O'Neill C, Paladenech C, Walker T, Pestronk A, Abrams B, Florence J, Renna R, Schierbecker J, Malkus B, Cudkowicz M.

Neurology. 2005 Dec 13;65(11):1834-6.

PMID:
16344537
46.

Proteomic profiling of cerebrospinal fluid identifies biomarkers for amyotrophic lateral sclerosis.

Ranganathan S, Williams E, Ganchev P, Gopalakrishnan V, Lacomis D, Urbinelli L, Newhall K, Cudkowicz ME, Brown RH Jr, Bowser R.

J Neurochem. 2005 Dec;95(5):1461-71.

47.

Deletion of the RIIbeta-subunit of protein kinase A decreases body weight and increases energy expenditure in the obese, leptin-deficient ob/ob mouse.

Newhall KJ, Cummings DE, Nolan MA, McKnight GS.

Mol Endocrinol. 2005 Apr;19(4):982-91. Epub 2004 Dec 23.

PMID:
15618289
48.

Approach to primary immunodeficiency.

Newhall KK, Uzel G.

Allergy Asthma Proc. 2004 Jul-Aug;25(4 Suppl 1):S59-60. Review. No abstract available.

PMID:
15515385
49.

Nonallergic rhinitis.

Newhall KK, McGrath KG.

Allergy Asthma Proc. 2004 Jul-Aug;25(4 Suppl 1):S13-5. Review. No abstract available.

PMID:
15515366
50.

Skin testing in allergy.

Newhall KK, Saltoun C.

Allergy Asthma Proc. 2004 Jul-Aug;25(4 Suppl 1):S5-6. Review. No abstract available.

PMID:
15515362

Supplemental Content

Loading ...
Support Center